本文選題：苯溴馬隆片 + 別嘌醇片　； 參考：《中國臨床藥理學(xué)雜志》2017年19期

【摘要】：目的比較苯溴馬隆與別嘌醇對急性腦梗死合并高尿酸血癥患者的臨床療效和安全性。方法將180例急性腦梗死并且合并高尿酸血癥患者隨機分為對照組60例,試驗A組60例,試驗B組60例,3組患者均給予腦梗死常規(guī)治療。對照組給予安慰劑(淀粉膠囊)25 mg,qd,口服。試驗A組給予別嘌醇100mg,bid,口服。試驗B組給予苯溴馬隆50 mg,qd,口服。3組患者均治療14 d。觀察3組患者的臨床療效,血尿酸(UA)、超敏C反應(yīng)蛋白(hs-CRP)、白細(xì)胞介素-6(IL-6)、頸動脈內(nèi)膜中膜厚度(IMT)的變化以及藥物不良反應(yīng)的發(fā)生情況。結(jié)果治療后,試驗A組、試驗B組和對照組的總有效率分別為88.33%(53/60例),95.00%(57/60例)和76.67%(46/60例),試驗A、B組分別與對照組比較,差異均有統(tǒng)計學(xué)意義(均P0.05),且試驗A組和試驗B組比較,差異有統(tǒng)計學(xué)意義(P0.05)。治療后,試驗A組、試驗B組和對照組的UA值分別為(237.31±10.63),(162.67±10.12),(586.52±50.60)μmol·L-1;hs-CRP分別為(4.93±0.68),(3.57±1.03),(12.07±0.54)mg·L-1;IL-6分別為(78.31±10.63),(68.67±10.12),(190.52±50.60)pg·m L-1;IMT分別為(1.08±0.25),(0.76±0.29),(1.42±0.54)mm,差異均有統(tǒng)計學(xué)意義(均P0.05)。試驗B組的UA、hs-CRP、IL-6及IMT值較試驗A組下降更為明顯,差異均有統(tǒng)計學(xué)意義(均P0.05)。3組患者均未發(fā)生明顯的藥物不良反應(yīng)。結(jié)論苯溴馬隆與別嘌醇均能夠有效降低急性腦梗死合并高尿酸血癥患者的尿酸水平,減輕機體的炎癥反應(yīng),有效改善動脈粥樣硬化的程度,且安全性高,但苯溴馬隆的治療效果更為顯著。
[Abstract]:Objective to compare the clinical efficacy and safety of benzene bromide Malone and allopurinol in patients with acute cerebral infarction with hyperuricemia. Methods 180 patients with acute cerebral infarction and hyperuricemia were randomly divided into 60 cases of control group, 60 cases in group A, 60 cases in group B, and 3 groups of patients given cerebral infarction routine treatment. The control group was given placebo (the placebo group). Starch capsules) 25 mg, QD, orally. Group A was given allopurinol 100mg, bid, oral administration. Group B was given benzene bromine Malone 50 mg, QD, and oral.3 group patients were treated with 14 d. to observe the clinical efficacy of 3 groups of patients, blood uric acid (UA), hypersensitivity C reactive protein, carotid intima membrane thickness and adverse drug reaction Results after treatment, the total effective rate of test A group, test group B and control group were 88.33% (53/60 cases), 95% (57/60 cases) and 76.67% (46/60 cases), test A, and B group compared with control group respectively, the difference was statistically significant (P0.05), and the difference was statistically significant (P0.05) compared with the experimental A group and the test B group. After treatment, test In group A, the UA values in group B and control group were (237.31 + 10.63), (162.67 + 10.12) and (586.52 + 50.60) Mu mol. L-1; hs-CRP was (4.93 + 0.68), (3.57 + 1.03), (12.07 + 0.54) mg. L-1, IL-6 (78.31 + 10.63), PG. M L-1, respectively. There were statistical significance (all P0.05). The values of UA, hs-CRP, IL-6 and IMT in group B were more obvious than those in the experimental A group. The difference was statistically significant (all P0.05) group.3 patients had no obvious adverse drug reactions. Conclusion benzene bromide Malone and allopurinol can effectively reduce the level of uric acid in patients with acute cerebral infarction and hyperuricemia, and reduce the level of uric acid in patients with acute cerebral infarction and hyperuricemia. The inflammatory reaction of light body can effectively improve the degree of atherosclerosis, and its safety is high, but the effect of benzbromine Malone is more significant.

【作者單位】： 武漢市第三醫(yī)院神經(jīng)內(nèi)科;
【分類號】：R589.7;R743.33

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 侯國存;孫秀麗;;苯溴馬隆致急性肝損傷1例[J];臨床醫(yī)藥實踐;2009年18期

2 陳錫創(chuàng);葉建林;謝楊芳;洪遠(yuǎn);;苯溴馬隆致雙足嚴(yán)重腫痛1例[J];醫(yī)藥導(dǎo)報;2014年05期

3 程虹;宋恩峰;任開明;;苯溴馬隆結(jié)合威草膠囊治療痛風(fēng)的臨床療效[J];武漢大學(xué)學(xué)報(醫(yī)學(xué)版);2009年02期

4 胡繼紅;龔翌;楊正英;;苯溴馬隆對延緩老年人腎功能減退的療效觀察[J];華南國防醫(yī)學(xué)雜志;2011年03期

5 楊媛;李靜;甄健存;趙業(yè)婷;付娜;;抗痛風(fēng)藥別嘌呤醇、苯溴馬隆及秋水仙堿不良反應(yīng)報告分析[J];中國醫(yī)院藥學(xué)雜志;2013年15期

6 陳德彥,王曉霞,刁祖蓉,徐治波,毛伯勤;國產(chǎn)苯溴馬隆治療高尿酸血癥50例[J];中國新藥雜志;2003年02期

7 朱羞陽;;苯溴馬隆片致眼結(jié)膜炎一例[J];中國療養(yǎng)醫(yī)學(xué);2009年06期

8 范麗霞;;丹紅注射液配合苯溴馬隆片治療痛風(fēng)實例[J];當(dāng)代醫(yī)學(xué);2011年10期

9 李美友;蔡巧敏;;加味四物湯聯(lián)合苯溴馬隆治療痛風(fēng)病30例[J];中國中醫(yī)藥現(xiàn)代遠(yuǎn)程教育;2013年23期

10 王大鵬;高燕燕;;非諾貝特和苯溴馬隆治療高尿酸血癥的效果[J];齊魯醫(yī)學(xué)雜志;2010年06期

相關(guān)重要報紙文章 前1條

1 解放軍292醫(yī)院主任醫(yī)師 張開富;巧用苯溴馬隆治痛風(fēng)[N];健康報;2002年

相關(guān)碩士學(xué)位論文 前1條

1 單瑞;苯溴馬隆與別嘌醇對心力衰竭伴高尿酸血癥患者炎癥因子及心功能的影響[D];天津醫(yī)科大學(xué);2014年

，

本文編號：1864534